Dr. Agarwal's Health Care Limited has announced that the National Company Law Tribunal (NCLT), Chennai Bench, will hear its petition for a scheme of amalgamation with Dr. Agarwal's Eye Hospital Limited on August 19, 2026. The joint petition was presented under Sections 230 to 232 of the Companies Act, 2013, seeking approval for the merger between the two entities and their respective shareholders and creditors.

The hearing follows an order dated July 15, 2026, from the Hon'ble NCLT, Chennai Bench. The company has published newspaper advertisements in Business Standard and Makkal Kural on July 20, 2026, to intimate stakeholders about the scheduled hearing.

Scheme Details

The amalgamation involves Dr. Agarwal's Eye Hospital Limited as the transferor company and Dr. Agarwal's Health Care Limited as the transferee company. The scheme encompasses the respective shareholders and creditors of both entities.

Shareholder and Creditor Participation

Any person desirous of supporting or opposing the petition must send a notice of intention to the advocate of the petitioner companies. The notice, signed by the individual or their advocate, must include the name and address and reach the advocate's office not later than two days before the hearing date.

Those opposing the petition are required to furnish the grounds of opposition or a copy of their affidavit along with the notice. The advocate's office is located at New No. 10, Old No. 28, Shankaralaya, 3rd Cross Street, RK Nagar, RA Puram, Chennai.

A copy of the petition will be made available to any person requiring it upon payment of the prescribed charges. The information is also accessible on the company's website.

Dr Agarwals Health Care Limited received approval from its equity shareholders for the scheme of amalgamation with Dr Agarwal's Eye Hospital Limited on Thursday, July 02, 2026. The resolution was passed with a requisite majority during a meeting convened by the National Company Law Tribunal (NCLT) at The Music Academy in Chennai. This approval marks a critical step towards the consolidation of the two entities under the provisions of the Companies Act, 2013.

The meeting was chaired by Shri L N Gupta, with Shri Shivam Parashar appointed as the Scrutinizer to oversee the voting process. Facilities were provided for remote e-voting, e-voting at the venue, and voting via polls. The remote e-voting period commenced on June 07, 2026, and concluded on July 01, 2026. The meeting was attended by 47 equity shareholders, fulfilling the requisite quorum of 30 equity shareholders as prescribed by the Hon'ble NCLT. The total number of shareholders as on the record date, June 03, 2026, was 43,122.

Equity Shareholders Voting Results

The combined voting results for the equity shareholders indicated overwhelming support for the amalgamation scheme. A total of 485 members participated, casting 30,40,15,565 valid votes in favor of the resolution. Votes against the resolution totaled 81,138.

Public Shareholder Voting

The votes cast by public shareholders, excluding the Promoter and Promoter Group, also approved the scheme. A total of 468 members cast 20,15,11,447 votes, with 20,14,30,309 votes in favour and 81,138 votes against.

Scheme Details and Conditions

The scheme of amalgamation involves Dr Agarwal's Eye Hospital Limited as the transferor company and Dr Agarwals Health Care Limited as the transferee company. The resolution authorizes the Board of Directors to take all necessary actions to implement the scheme, subject to the sanction of the Hon'ble NCLT and other regulatory approvals. The scrutinizer's report confirms that the resolution was duly approved on July 02, 2026. The electronic voting data and polling papers will be handed over to Thanikainathan Arumugam, the Company Secretary and Compliance Officer of Dr Agarwals Health Care Limited.